10x Science Accelerates AI Drug Discovery with $4.8M Seed Round

business#biotech📰 News|Analyzed: Apr 22, 2026 13:10
Published: Apr 22, 2026 13:00
1 min read
TechCrunch

Analysis

This is an incredibly exciting development for the intersection of artificial intelligence and biotechnology. While AI models like Google DeepMind's have revolutionized the prediction of protein structures, 10x Science is solving the next crucial step by effectively characterizing these candidates for real-world testing. By bridging the gap between computational prediction and practical biological application, this startup is poised to dramatically accelerate the development of life-saving biologic drugs.
Reference / Citation
View Original
"“You can add as many candidates as you want to the top of the funnel, but they all have to pass through this characterization process. Everything needs to be measured.”"
T
TechCrunchApr 22, 2026 13:00
* Cited for critical analysis under Article 32.